Based on the company's latest reports for June 2025, the current 12-month EPS is $5.19. Encompass Health's earnings per share in 2024 was reported at $4.53, marking a rise from $3.51 in 2023. In the quarterly report ending on Jun 30, 2025, EHC's earnings per share amounted to $1.41.
Encompass Health had an yealy earnings per share of $4.53, showing a rise of 29.1% from $3.51 recorded in 2023. The quarterly earnings per share for the period ending Jun 30, 2025, was $1.41, showing a 24.8% increase compared to the same quarter last year. The trailing twelve months EPS for EHC is $5.19 as of June 2025. Encompass Health's full-year EPS for 2023 was $3.51, a 29% rise compared to the previous year.
In the past 12 months, Encompass Health has recorded an earnings per share growth rate of 24.8% (YoY, quarterly). Over an extended period, the company registered an average EPS annual growth rate of 3% per year during the last 3 years. In the last five years, the company had an average annual EPS growth of 4.4%. A ten-year view shows that EHC has seen an average earnings per share growth of 6.3% per year.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
NUTX Nutex Health Inc | 6.75 | 198.7% | -32.3% | N/A |
SEM Select Medical Holdings Corp | 11.28 | -13.1% | -17.7% | 8.6% |
EHC Encompass Health Corp | 22.66 | 29.1% | 3% | 4.4% |
All data is based on quarterly TTM periods, unless otherwise specified.